HB872 allows county departments and agencies, public schools, and other entities to stock auto-injectable epinephrine and permits trained employees.
HB872 aims to improve public health by increasing access to epinephrine, a critical treatment for severe allergic reactions. The bill allows county departments and agencies, public schools, and other authorized entities to stock auto-injectable epinephrine. Employees and agents of these entities can administer epinephrine to individuals experiencing anaphylaxis, even without a prescription or prior diagnosis. To do so, they must complete an anaphylaxis training program.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.